NewsBenzingaReported Earlier, United Therapeutics Prevails In Delaware Court Ruling Finding Liquidia Infringes Two Claims Of Patent On Inhaled Treprostinil For PH-ILD Via Yutrepia Marketing Reported Earlier, United Therapeutics Prevails In Delaware Court Ruling Finding Liquidia Infringes Two Claims Of Patent On Inhaled Treprostinil For PH-ILD Via Yutrepia Marketing Benzinga 2026.10.01 06:15 (GMT+0) Open on Benzinga Other news Goldman Sachs Reinstates Neutral on Enbridge, Announces $50 Price Target Ascendiant Capital Maintains Buy on SINTX Technologies, Raises Price Target to $12.5 Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50 Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $25 Elon Musk Says Starship Could Supercharge Astronomy With Massive Space Telescopes — and ‘Giant Ones’ on the Moon Needham Maintains Buy on Liquidia, Lowers Price Target to $72
Elon Musk Says Starship Could Supercharge Astronomy With Massive Space Telescopes — and ‘Giant Ones’ on the Moon
